Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit at Rs 894.15 crore for the quarter ended March 2021, mainly on account of a robust performance in the Indian market.

The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.

Consolidated total revenue from operations stood at Rs 8,522.98 crore for the quarter under consideration compared with Rs 8,184.94 crore in the same period a year ago.

The full year consolidated profits were, however, down 22.87 per cent at Rs 2,903.82 crore from Rs 3,764.93 crore a year ago.

Wockhardt loss

Drug firm Wockhardt on Thursday reported a consolidated net loss of Rs 106.84 crore for the quarter ended March 31, 2021. The company had posted a net profit of Rs 68.51 crore in the corresponding period of the previous fiscal.

The consolidated total income of the company for the reporting quarter stood at Rs 639.50 crore, down from Rs 700.66 crore in the same period a year ago.

For the financial year ended March this year, the company posted a net profit of Rs 688.60 crore against a loss of Rs 43.39 crore in 2019-20.

Cadila show

Drug firm Cadila Healthcare on Thursday reported a 73.5 per cent rise in its consolidated net profit at Rs 679 crore for the March quarter. The company had posted a net profit of Rs 391.9 crore a year ago.

Consolidated total revenue from operations stood at Rs 3,846.7 crore compared with Rs 3,752 crore a year ago.